Allogeneic bone marrow transplantation without graft-v-host disease: true tolerance of graft against the host through depletion of donor T lymphocytes pregrafting in malignant and nonmalignant disorders.
Slavin
S
S
Department of Bone Marrow Transplantation, Hadassah-Hebrew University Hospital, School of Medicine, Jerusalem, Israel.
Or
R
R
Naparstek
E
E
Weiss
L
L
Mumcuoglu
M
M
Weshler
Z
Z
Brautbar
H
H
Cividalli
G
G
Glikson
M
M
Hale
G
G
D000741:Anemia, Aplastic / Q000601:surgery*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001803:Blood Transfusion; D016026:Bone Marrow Transplantation / Q000276:immunology*; D006086:Graft vs Host Disease / Q000517:prevention & control*; D006650:Histocompatibility Testing; D006801:Humans; D007108:Immune Tolerance; D007153:Immunologic Deficiency Syndromes / Q000601:surgery*; D007165:Immunosuppression Therapy / Q000379:methods; D007938:Leukemia / Q000601:surgery*; D008212:Lymphocyte Depletion; D009369:Neoplasms / Q000601:surgery*; D013601:T-Lymphocytes / Q000276:immunology*; D013789:Thalassemia / Q000601:surgery*; D014184:Transplantation, Homologous
D000911:Antibodies, Monoclonal